These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26761372)

  • 1. Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment.
    Yuksel M; Yildiz A; Tapan U; Ertas F; Alan S
    Arq Bras Cardiol; 2015 Dec; 105(6):642-6. PubMed ID: 26761372
    [No Abstract]   [Full Text] [Related]  

  • 2. Rivaroxaban twice daily for lysis of left atrial appendage thrombus: a potential new therapeutic option.
    Piotrowski R; Zaborska B; Baran J; Sikora-Frąc M; Kułakowski P
    Pol Arch Med Wewn; 2016 Jun; 126(6):430-1. PubMed ID: 27305139
    [No Abstract]   [Full Text] [Related]  

  • 3. Rivaroxaban for the treatment of cerebral venous thrombosis.
    Mutgi SA; Grose NA; Behrouz R
    Int J Stroke; 2015 Oct; 10 Suppl A100():167-8. PubMed ID: 26502976
    [No Abstract]   [Full Text] [Related]  

  • 4. Adding rivaroxaban to aspirin after CABG surgery.
    Lim GB
    Nat Rev Cardiol; 2019 Mar; 16(3):133. PubMed ID: 30692655
    [No Abstract]   [Full Text] [Related]  

  • 5. Rivaroxaban for cancer-associated cardiac thrombosis.
    Di Nisio M; Carella C; Natoli C; Porreca E; De Tursi M
    Am J Med; 2015 Oct; 128(10):e43-4. PubMed ID: 26071831
    [No Abstract]   [Full Text] [Related]  

  • 6. Rivaroxaban for thromboprophylaxis in a patient receiving electroconvulsive therapy.
    Shuman M; Hieber R; Moss L; Patel D
    J ECT; 2015 Mar; 31(1):e19-20. PubMed ID: 25587812
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early recanalization of veins in patients with DVT treated with rivaroxaban: do we need to move from bedside to bench again?
    Ramacciotti E; Volpiani GG; Dávila R; Resende Aguiar VC; Silveira Magella FM; Fareed J
    Int Angiol; 2018 Feb; 37(1):1-3. PubMed ID: 28945062
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent deep vein thrombosis with rivaroxaban in a patient with metastatic testicular cancer.
    Eid TJ; Kalkat B; Shah SA
    J Pharm Pract; 2015 Jun; 28(3):233. PubMed ID: 25979903
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.
    Tardy-Poncet B; Piot M; Montmartin A; Burdier A; Chalayer E; Tardy B
    Thromb Haemost; 2015 Aug; 114(3):652-4. PubMed ID: 26062524
    [No Abstract]   [Full Text] [Related]  

  • 11. Case series of recalcitrant livedoid vasculopathy treated with rivaroxaban.
    Lee JM; Kim IH
    Clin Exp Dermatol; 2016 Jul; 41(5):559-61. PubMed ID: 26993107
    [No Abstract]   [Full Text] [Related]  

  • 12. Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome.
    Daaboul Y; Korjian S; Plotnikov AN; Burton P; Braunwald E; Wiviott SD; Gibson CM
    J Am Coll Cardiol; 2018 Mar; 71(9):1048-1049. PubMed ID: 29495985
    [No Abstract]   [Full Text] [Related]  

  • 13. Rivaroxaban for Left Ventricular Thrombus.
    Yassin AS; Abubakar H; Mishra T; Adam O; Hartman M; Pahuja M; Shokr M
    Am J Ther; 2019; 26(4):e511-e515. PubMed ID: 29420319
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Rivaroxaban for Mesenteric Vein Thrombosis Secondary to Diverticulitis: A Case Report.
    Parthvi R; Mehra S
    Am J Ther; 2017; 24(5):e629-e630. PubMed ID: 27759584
    [No Abstract]   [Full Text] [Related]  

  • 15. [New Anticoagulants in the Treatment of Patients With Recent Acute Coronary Syndrome. Place of Rivaroxaban].
    Hirmanov VN
    Kardiologiia; 2015; 55(6):98-104. PubMed ID: 26625526
    [No Abstract]   [Full Text] [Related]  

  • 16. Practical management of rivaroxaban for the treatment of venous thromboembolism.
    Imberti D; Benedetti R
    Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-vitamin K antagonist oral anticoagulants (NOACs) in the cardiac catherisation laboratory: Friends or Foes?
    Htun NM; Peter K
    Thromb Haemost; 2015 Aug; 114(2):214-6. PubMed ID: 25995026
    [No Abstract]   [Full Text] [Related]  

  • 18. Superior mesenteric artery thrombosis after abrupt discontinuation of rivaroxaban.
    Adams CB; Acquisto NM; Rotoli JM; LoStracco T; Shamaskin AR; Pasternack JS
    Am J Emerg Med; 2016 Apr; 34(4):764.e5-7. PubMed ID: 26439093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality.
    Esteve-Pastor MA; Orenes-Piñero E; Roldán V; Lacunza-Ruiz J; Valdés M; Marín F
    Cardiol J; 2018; 25(1):151-154. PubMed ID: 29512103
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of rivaroxaban in left ventricular thrombi.
    Abdelnaby M; Almaghraby A; Abdelkarim O; Saleh Y; Hammad B; Badran H
    Anatol J Cardiol; 2019 Jan; 21(1):47-50. PubMed ID: 30587707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.